Indegene · NSE: INDGN · BSE: 544172
Q3 FY25 results · Oct–Dec 2024
Indegene reported revenue from operations of ₹720.40 crore and net profit of ₹109.70 crore for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 720.40 | — | — | 686.80 | +4.9% |
| Other income | 37.70 | — | — | 21.40 | +76.2% |
| Total income | 758.10 | — | — | 708.20 | +7.0% |
| Profit before tax | 146.30 | — | — | 124.10 | +17.9% |
| Net profit for the period | 109.70 | — | — | 91.70 | +19.6% |
| EPS, basic (₹) | 4.59 | — | — | 3.84 | +19.5% |
| Net margin (%) | 15.2 | — | 13.4 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 286.70 | — | — | 281.70 | +1.8% |
| Other income | 22.30 | — | — | 22.40 | −0.4% |
| Total income | 309.00 | — | — | 304.10 | +1.6% |
| Profit before tax | 66.10 | — | — | 61.00 | +8.4% |
| Net profit for the period | 49.90 | — | — | 44.80 | +11.4% |
| EPS, basic (₹) | 2.09 | — | — | 1.88 | +11.2% |
| Net margin (%) | 17.4 | — | 15.9 |
Consolidated
- Filed with BSE
- 30 Jan 2025, 17:44 IST
- Board meeting
- 30 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Jan 2025, 17:44 IST
- Board meeting
- 30 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE